Wyeth two-rod levonorgestrel contraceptive implant launch awaits approval of new insertion trocar.
Executive Summary
WYETH-AYERST TWO-ROD LEVONORGESTREL IMPLANT LAUNCH AWAITS completion of research to support a 510(k) application for a new trocar, the company indicated. FDA approved Wyeth-Ayerst's NDA (20-627) for the contraceptive Aug. 15. The two-rod, 150 mg implant would provide three years of contraception; Wyeth's six-rod Norplant levonorgestrel implant provides five years of contraception.